Nuo Therapeutics Inc (AURX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nuo Therapeutics Inc (AURX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7478
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company’s flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient’s innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has its facilities in Nashville, Tennessee; and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc (AURX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nuo Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Aldagen Raises Additional US$0.06 Million In Venture Financing 10
Partnerships 11
Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11
Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12
Nuo Therapeutics Amends Licensing Agreement with Arthrex 13
Equity Offering 14
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 19
Cytomedix Completes Private Placement Of Shares For US$7 Million 20
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 21
Acquisition 22
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22
Nuo Therapeutics Inc – Key Competitors 24
Nuo Therapeutics Inc – Key Employees 25
Nuo Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Legal and Regulatory 27
Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Nuo Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aldagen Raises Additional US$0.06 Million In Venture Financing 10
Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11
Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12
Nuo Therapeutics Amends Licensing Agreement with Arthrex 13
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 19
Cytomedix Completes Private Placement Of Shares For US$7 Million 20
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 21
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22
Nuo Therapeutics Inc, Key Competitors 24
Nuo Therapeutics Inc, Key Employees 25
Nuo Therapeutics Inc, Other Locations 26
Nuo Therapeutics Inc, Subsidiaries 26

List of Figures
Nuo Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Nuo Therapeutics Inc (AURX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Eiffage SA (FGR):電力:M&Aディール及び事業提携情報
    Summary Eiffage SA (Eiffage) is a construction and concession company. It operates in businesses of energy and infrastructure construction, real estate development, road construction, civil engineering, concessions, and public-private partnerships. The company’s activities include construction, reno …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OncoStem Diagnostics Pvt. Ltd:企業の製品パイプライン分析2018
    Summary OncoStem Diagnostics Pvt Ltd (OncoStem) is a provider of clinical trial solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoS …
  • Canon Inc.:企業の戦略・SWOT・財務情報
    Canon Inc. - Strategy, SWOT and Corporate Finance Report Summary Canon Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Shopper’S Stop Ltd.:企業の戦略・SWOT・財務分析
    Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NexTier Oilfield Solutions Inc (NEX):企業の財務・戦略的SWOT分析
    NexTier Oilfield Solutions Inc (NEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Humabs BioMed SA-製薬・医療分野:企業M&A・提携分析
    Summary Humabs BioMed SA (Humabs) is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company’s pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develops cellclone technologies, a proprietary …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Uber Technologies Inc:企業の戦略・SWOT・財務情報
    Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NACHI-FUJIKOSHI CORP.:企業の戦略・SWOT・財務情報
    NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report Summary NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Barry Callebaut AG:企業の戦略・SWOT・財務情報
    Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report Summary Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Catholic Health Initiatives:企業の戦略的SWOT分析
    Catholic Health Initiatives - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Suzuken Co Ltd (9987):企業の財務・戦略的SWOT分析
    Suzuken Co Ltd (9987) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • UBM plc:企業のM&A・事業提携・投資動向
    UBM plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UBM plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • American Cancer Society Inc:企業の戦略的SWOT分析
    American Cancer Society Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Scienion AG:医療機器:M&Aディール及び事業提携情報
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Verde Science Inc (VRCI):企業の財務・戦略的SWOT分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a pharmaceutical research and development company that explores phytochemicals and drugs to create novel formulations. The company offers research and development services in bioprocess technology, molecular virology and immunol …
  • LyondellBasell Industries N.V.:企業の戦略・SWOT・財務情報
    LyondellBasell Industries N.V. - Strategy, SWOT and Corporate Finance Report Summary LyondellBasell Industries N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆